MA49448A - Compositions pharmaceutiques contenant du fumarate de diméthyle - Google Patents

Compositions pharmaceutiques contenant du fumarate de diméthyle

Info

Publication number: MA49448A
Authority: MA; Morocco
Prior art keywords: pharmaceutical compositions; compositions containing; dimethyl fumarate; containing dimethyl; fumarate
Prior art date: 2017-06-23

Application number

MA049448A

Other languages

English (en)

Inventor

Mir Jorge Aubets

Original Assignee

Almirall Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-06-23

Filing date

2018-06-25

Publication date

2020-04-29

2017-06-23 Priority claimed from GBGB1710114.8A external-priority patent/GB201710114D0/en

2018-06-25 Application filed by Almirall Sa filed Critical Almirall Sa

2020-04-29 Publication of MA49448A publication Critical patent/MA49448A/fr

Links

LDCRTTXIJACKKU-ONEGZZNKSA-N dimethyl fumarate Chemical compound COC(=O)\C=C\C(=O)OC LDCRTTXIJACKKU-ONEGZZNKSA-N 0.000 title 1
229960004419 dimethyl fumarate Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Inorganic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MA049448A 2017-06-23 2018-06-25 Compositions pharmaceutiques contenant du fumarate de diméthyle MA49448A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1710114.8A GB201710114D0 (en)	2017-06-23	2017-06-23	Pharmaceutical compositions
EP17382402		2017-06-27

Publications (1)

Publication Number	Publication Date
MA49448A true MA49448A (fr)	2020-04-29

Family

ID=62791731

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA049448A MA49448A (fr)	2017-06-23	2018-06-25	Compositions pharmaceutiques contenant du fumarate de diméthyle

Country Status (9)

Country	Link
US (1)	US11602515B2 (fr)
EP (1)	EP3641736A1 (fr)
JP (1)	JP7308763B2 (fr)
KR (1)	KR20200018458A (fr)
CN (1)	CN110636838A (fr)
AU (1)	AU2018287442A1 (fr)
CA (1)	CA3059293A1 (fr)
MA (1)	MA49448A (fr)
WO (1)	WO2018234584A1 (fr)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19853487A1 (de)	1998-11-19	2000-05-25	Fumapharm Ag Muri	Verwendung von Dialkylfumaraten
DE10101307A1 (de)	2001-01-12	2002-08-01	Fumapharm Ag Muri	Fumarsäurederivate als NF-kappaB-Inhibitor
LT2801354T (lt)	2004-10-08	2017-06-26	Forward Pharma A/S	Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
MX2007013467A (es)	2005-04-28	2008-01-21	Wyeth Corp	Tanaproget micronizado y composiciones que contienen el mismo.
WO2007042035A2 (fr)	2005-10-07	2007-04-19	Aditech Pharma Ab	Therapie de combinaison pour le traitement d'un trouble auto-immun et/ou inflammatoire et de conditions associees
US20080299196A1 (en)	2005-10-07	2008-12-04	Aditech Pharma Ab	Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
WO2009118764A1 (fr)	2008-03-28	2009-10-01	Panacea Biotec Limited	Composition pharmaceutique comprenant du diclofénac et du paracétamol
WO2010079222A1 (fr)	2009-01-09	2010-07-15	Forward Pharma A/S	Formule pharmaceutique comportant un ou plusieurs esters d'acide fumarique dans une matrice érosive
JP2012514623A (ja)	2009-01-09	2012-06-28	フォーワード・ファルマ・アクティーゼルスカブ	１またはそれ以上のフマル酸エステルを含む医薬組成物
US20120165404A1 (en)	2009-04-29	2012-06-28	Biogen Idec Ma Inc.	Treatment of neurodegeneration and neuroinflammation
KR20140040728A (ko)	2011-06-03	2014-04-03	에프. 호프만-라 로슈 아게	Pi3k 억제제 화합물을 사용한 중피종 치료 방법
NZ627980A (en)	2012-02-07	2016-12-23	Biogen Ma Inc	Pharmaceutical compositions containing dimethyl fumarate
JP6581088B2 (ja)	2013-12-12	2019-09-25	アルミラル・ソシエダッド・アノニマＡｌｍｉｒａｌｌ，Ｓ．Ａ．	フマル酸ジメチルを含む医薬組成物
MA40982A (fr)	2014-11-19	2017-09-26	Biogen Ma Inc	Formulation de bille pharmaceutique comprenant du fumarate de diméthyle

2018
- 2018-06-25 MA MA049448A patent/MA49448A/fr unknown
- 2018-06-25 KR KR1020197037153A patent/KR20200018458A/ko not_active Ceased
- 2018-06-25 WO PCT/EP2018/066970 patent/WO2018234584A1/fr not_active Ceased
- 2018-06-25 CN CN201880032458.1A patent/CN110636838A/zh active Pending
- 2018-06-25 EP EP18735535.9A patent/EP3641736A1/fr not_active Withdrawn
- 2018-06-25 US US16/625,092 patent/US11602515B2/en active Active
- 2018-06-25 JP JP2019570520A patent/JP7308763B2/ja active Active
- 2018-06-25 CA CA3059293A patent/CA3059293A1/fr active Pending
- 2018-06-25 AU AU2018287442A patent/AU2018287442A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20200197348A1 (en)	2020-06-25
WO2018234584A1 (fr)	2018-12-27
CA3059293A1 (fr)	2018-12-27
EP3641736A1 (fr)	2020-04-29
CN110636838A (zh)	2019-12-31
JP2020524685A (ja)	2020-08-20
US11602515B2 (en)	2023-03-14
AU2018287442A1 (en)	2019-11-07
JP7308763B2 (ja)	2023-07-14
KR20200018458A (ko)	2020-02-19

Publication	Publication Date	Title
EP3565550A4 (fr)	2020-01-22	Compositions pharmaceutiques contenant du méloxicam
EP3621621A4 (fr)	2021-03-31	Compositions pharmaceutiques contenant du méloxicam
EP3256138A4 (fr)	2019-10-02	Compositions pharmaceutiques contenant du méloxicam
EP3615040C0 (fr)	2025-02-26	Compositions de traitement capillaire
DK3529248T3 (da)	2020-09-14	Farmaceutiske sammensætninger
IL257531A (en)	2018-04-30	Therapeutic combinations comprising anti-folr1 immunoconjugates
EP3513809A4 (fr)	2020-06-03	Composition médicinale
EP2811994A4 (fr)	2016-01-13	Compositions pharmaceutiques contenant du fumarate de diméthyle
DK3655017T3 (da)	2025-03-31	Farmaceutisk sammensætning
PT3500255T (pt)	2023-01-10	Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
EP3641771A4 (fr)	2020-12-16	Compositions pharmaceutiques
MA49947A (fr)	2021-04-21	Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
EP3415008A4 (fr)	2019-09-11	Composition germicide
DK3709978T3 (da)	2023-06-12	Farmaceutisk oral formulering omfattende bakterier
DK3634377T3 (da)	2021-08-30	Farmaceutisk formulering
EP3610851A4 (fr)	2020-09-23	Composition d'agent nettoyant pour la peau
DK3583943T3 (da)	2024-10-14	Farmaceutisk sammensætning
MA49837A (fr)	2020-06-17	Compositions pharmaceutiques
EP3582759A4 (fr)	2021-01-06	Composition pharmaceutique bioéquivalente de bromhydrate de vortioxétine
EP3773613A4 (fr)	2022-01-05	Compositions pharmaceutiques contenant des polyrotaxanes
SMT202400478T1 (it)	2025-01-14	Composizione farmaceutica
EP3646863A4 (fr)	2021-03-24	Composition pharmaceutique
EP3610847A4 (fr)	2020-12-16	Composition d'agent nettoyant pour la peau
DK3601277T3 (da)	2024-01-15	Farmaceutisk formulering
EP3646864A4 (fr)	2021-03-17	Composition pharmaceutique contenant du pémafibrate